Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 29 min 32 sec ago

Google Cloud introduces digital suite for medical imaging

5 hours 5 min ago
Google Cloud introduces digital suite for medical imaging chale Tue, 10/04/2022 - 14:06

Dexcom's G7 diabetes sensor begins European, international debut

6 hours 20 min ago
Dexcom's G7 diabetes sensor begins European, international debut chale Tue, 10/04/2022 - 12:52

HHS preps for potential pandemics, gives Vir Biotechnology chance to make up to $1B in multiyear contract

6 hours 45 min ago
HHS preps for potential pandemics, gives Vir Biotechnology chance to make up to $1B in multiyear contract gmasson Tue, 10/04/2022 - 12:27

With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays

8 hours 7 min ago
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays mbayer Tue, 10/04/2022 - 11:04

BMS wants light bulb moment, pens deal for access to Autolus’ CAR-T switch

8 hours 36 min ago
BMS wants light bulb moment, pens deal for access to Autolus’ CAR-T switch gmasson Tue, 10/04/2022 - 10:35

Mission in-Komplete: KalVista axes angioedema program over raised enzyme levels

10 hours 32 sec ago
Mission in-Komplete: KalVista axes angioedema program over raised enzyme levels jwaldron Tue, 10/04/2022 - 09:11

Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease

10 hours 33 min ago
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease ntaylor Tue, 10/04/2022 - 08:38

Sanofi spies miRecule therapy, wagering $400M in biobucks to go after muscular dystrophy with RNA

11 hours 18 min ago
Sanofi spies miRecule therapy, wagering $400M in biobucks to go after muscular dystrophy with RNA ntaylor Tue, 10/04/2022 - 07:54

Flagship-founded Cellarity tacks on $121M series C to fund cell behaviour pipeline

Mon, 10/03/2022 - 14:30
Flagship-founded Cellarity tacks on $121M series C to fund cell behaviour pipeline mbayer Mon, 10/03/2022 - 17:30

'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal

Mon, 10/03/2022 - 13:55
'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal gmasson Mon, 10/03/2022 - 16:55

PACT unveils teased business venture, sells off select assets and South San Francisco facility to AmplifyBio

Mon, 10/03/2022 - 10:37
PACT unveils teased business venture, sells off select assets and South San Francisco facility to AmplifyBio mbayer Mon, 10/03/2022 - 13:37

Pain relief without opioids' ill effects? Researchers find new molecules

Mon, 10/03/2022 - 09:50
Pain relief without opioids' ill effects? Researchers find new molecules hfloersh Mon, 10/03/2022 - 12:50

Northwestern spinout looks to adapt COVID platform for monkeypox tests

Mon, 10/03/2022 - 08:19
Northwestern spinout looks to adapt COVID platform for monkeypox tests chale Mon, 10/03/2022 - 11:19

SPAC on track: Preclinical T-cell company Estrella latest in string of biotechs to take blank check route

Mon, 10/03/2022 - 07:23
SPAC on track: Preclinical T-cell company Estrella latest in string of biotechs to take blank check route gmasson Mon, 10/03/2022 - 10:23

Roche Diagnostics taps North American head Sause to be next CEO

Mon, 10/03/2022 - 07:19
Roche Diagnostics taps North American head Sause to be next CEO chale Mon, 10/03/2022 - 10:19

Not so Clene break: Biotech’s shares slump 34% on phase 2 ALS flop despite plans to continue testing

Mon, 10/03/2022 - 07:14
Not so Clene break: Biotech’s shares slump 34% on phase 2 ALS flop despite plans to continue testing jwaldron Mon, 10/03/2022 - 10:14

Incyte scoops up preclinical biotech to widen footprint in vitiligo

Mon, 10/03/2022 - 07:07
Incyte scoops up preclinical biotech to widen footprint in vitiligo mbayer Mon, 10/03/2022 - 10:07

Spying a devilish deal, AstraZeneca pays 666% premium to buy genomic medicine biotech

Mon, 10/03/2022 - 05:15
Spying a devilish deal, AstraZeneca pays 666% premium to buy genomic medicine biotech ntaylor Mon, 10/03/2022 - 08:15

Mesoblast keeps hopes of cell therapy approval alive in latest response to FDA

Mon, 10/03/2022 - 05:08
Mesoblast keeps hopes of cell therapy approval alive in latest response to FDA jwaldron Mon, 10/03/2022 - 08:08

After $100M deal, J&J links gene therapy to improved vision in early-phase trial

Mon, 10/03/2022 - 04:26
After $100M deal, J&J links gene therapy to improved vision in early-phase trial ntaylor Mon, 10/03/2022 - 07:26